Adaptive Designs in Clinical Trials 2019

01/04/2019 - 02/04/2019

SMi Group are proud to announce the 11th annual Adaptive Designs in Clinical Trials conference and exhibition will return to London from the 1st – 2nd April 2019. With the growing popularity in use and acceptance of adaptive designs in clinical trials – demonstrated most recently with the new FDA draft guidance on adaptive designs – there is a pressing need for a forum which explores this increasingly normalized medical methodology.

Hosting in depth presentations from regulatory agencies, researchers and biostatisticians, the meeting will cover how personalized medicine, platform trials, response-adaptive randomization, signature designs, estimand framework, Bayesian methods and digital innovation are revolutionizing the drug development process both in Europe and North America.

The benefits of attending:

At this year’s conference there will once again be an array of networking opportunities:

  • Meet and network with key industry and thought leaders shaping state of the art adaptive design techniques
  • More than 4 hours of networking during the conference days
  • Engage with an array of vendors, with leading solution providers, Mevia and GCE Solutions among those exhibiting last year

Key reasons to attend:

  • See how the regulatory environment for adaptive drug design is shifting across the continent with insights from the MHRA, Amgen, AstraZeneca and Berry Consulting
  • Explore the therapeutic potential of adaptive designs with real-world examples from H.Lundbeck, GSK Vaccines, Pfizer and Novartis
  • Listen to how the latest platform trial case studies – such as that of the EPAD project and the MS Society initiative, are impacting pharmaceutical development
  • Delve into the long-standing discussion of Bayesian vs. frequentist designs
  • Discover the latest research in response-adaptive designs: trials for rare diseases and looking forward

Chairs for 2019:

Alex Sverdlov, Director, Statistical Scientist, Novartis

Tom Parke, Director of Software Solutions, Berry Consulting

Featured Speakers:

  • Sandeep Menon, Vice President and Head of Early Clinical Development, Pfizer
  • Simon Wandel, Associate Director, Statistical Methodology and Consulting, Novartis
  • Solange Corriol-Rohou, Senior Director Regulatory Addairs & Policy, Europe, AstraZeneca*
  • Christine Fletcher, Executive Director Biostatistics, Amgen
  • Philip Hougaard, Vice President Biometrics, H. Lundbeck
  • Beatrice Panico, Medical Assessor, MHRA
  • Kaspar Rufi bach, Principal Statistical Scientist, Roche
  • Andrea Callegaro, Senior Manager, Biostatistician, GSK Vaccines



Additional Contact Info:

T: +44 (0)20 7827 6088


LinkedIn: @SMi Pharma

Twitter: #SMi & #smiadaptivedesigns